Description
Pharmaceutical Chemical Tacrolimus Powder CAS 104987-11-3 For Immunosuppression
Description
| Cas: | 104987-11-3 | Purity: | 99% |
|---|---|---|---|
| MF: | C44 H69 N O12 | MW: | 804.02 |
| COA: | AVAILABLE | COLOR: | WHITE |
| High Light: |
Tacrolimus Powder CAS 104987-11-3, 99% Chemical Tacrolimus Powder |
||
Pharmaceutical Chemicasl Tacrolimus Powder CAS 104987-11-3 for Immunosuppression
| Name | Tacrolimus |
| COA | AVAILABLE |
| Shelf Life | 2 years |
| Origin | China |
Tacrolimus topical (for the skin) is used short term to treat moderate to severe eczema in adults and children at least 2 years old.
tacrolimus topical is not for use in people who have a weak immune system.
Before taking this medicine:
You should not use tacrolimus if you are allergic to it.
Not approved for anyone younger than 2 years old.
Tacrolimus ointment in 0.03% or 0.1% strengths may be used by adults and children 16 years and older. Only the 0.01% strength should be used on a child 2 to 15 years old.
Tell your doctor if you have ever had:
- skin cancer;
- a bacterial or viral skin infection (including herpes or chickenpox);
- Netherton’s syndrome (a genetic skin disorder); or
- a weak immune system (caused by disease or by using certain medicine).
A small number of people using tacrolimus or pimecrolimus skin medications have developed skin cancer or lymphoma. However, it is not known if either of these medicines causes cancer. Ask your doctor about your risk.
It is not known if tacrolimus topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Do not breastfeed.
Tag:
